News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Sales of branded anti-obesity drugs (AOB) could hit $44 billion in 2030 vs. $2.5 billion in 2022, with just under 70% stemming from the US, according to a report from Bloomberg Intelligence.
mRNA technology is a “game-changer” for Asia-Pacific (APAC) vaccine manufacturers, according to a new report by science and technology company Merck.
Lifebit and Flatiron Health have announced a multi-year strategic partnership to support cancer research and enable scientific discoveries.